Ophdiat(®): five-year experience of a telemedical screening programme for diabetic retinopathy in Paris and the surrounding area.

AIM: This report describes our 5 years of experience with the ophthalmological diabetes telemedical network Ophdiat(®), designed to screen for diabetic retinopathy. METHODS: Seventeen hospitals, 11 primary healthcare centres and two prisons in the Paris area were gradually equipped with a non-mydriatic funduscopic camera between June 2004 and December 2009. Photos were taken by trained orthoptists and nurses, and interpreted by an average of seven certified ophthalmologists. The software was updated twice in 2008. RESULTS: In all, 38,596 patients were screened during 51,741 examinations between June 2004 and December 2009. Of these patients, 13,726 (26.55%) were referred to an ophthalmologist because of unreadable photographs (9.94%), advanced stages of retinopathy (14.71%) or concomitant eye diseases (1.90%). Patients screened in hospitals and prisons exhibited a greater prevalence of retinopathy and at more advanced stages. CONCLUSION: Telemedicine is a screening method that is well adapted for diabetic patients. In view of the increasing number of such patients and the decreasing number of ophthalmologists, expansion of the Ophdiat(®) screening network is desirable.

Endogenous endophthalmitis with azole-resistant Candida albicans--Case report and review of the literature.

Candida endophthalmitis accounts for the majority of fungal endophthalmitis. Despite its clinical relevance there are no controlled trials on different treatment regimens. We report a case of endogenous endophthalmitis caused by azole-resistant Candida albicans following abdominal surgery in an otherwise healthy woman, and review the literature concerning treatment recommendations. In consideration of the serious outcome with loss of sight in insufficiently treated endophthalmitis we like to increase awareness to this disease entity and the possibility of azole-resistance, even in treatment-naive patients.